BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15181171)

  • 1. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.
    Mitchell A; Dass CR; Sun LQ; Khachigian LM
    Nucleic Acids Res; 2004; 32(10):3065-9. PubMed ID: 15181171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
    Fahmy RG; Khachigian LM
    Nucleic Acids Res; 2004; 32(7):2281-5. PubMed ID: 15107496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
    Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
    Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
    Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
    Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of early growth response genes in human prostate cancer.
    Eid MA; Kumar MV; Iczkowski KA; Bostwick DG; Tindall DJ
    Cancer Res; 1998 Jun; 58(11):2461-8. PubMed ID: 9622090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression and activity of the immediate-early growth response (Egr-1) gene product during cellular senescence.
    Meyyappan M; Wheaton K; Riabowol KT
    J Cell Physiol; 1999 Apr; 179(1):29-39. PubMed ID: 10082129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
    Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
    Sakaue M; Adachi H; Dawson M; Jetten AM
    Cell Death Differ; 2001 Apr; 8(4):411-24. PubMed ID: 11550093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental regulation of galactokinase in suckling mouse liver by the Egr-1 transcription factor.
    Yang F; Agulian T; Sudati JE; Rhoads DB; Levitsky LL
    Pediatr Res; 2004 May; 55(5):822-9. PubMed ID: 14973178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.
    Niewiarowska J; Sacewicz I; Wiktorska M; Wysocki T; Stasikowska O; Wagrowska-Danilewicz M; Cierniewski CS
    Cancer Gene Ther; 2009 Sep; 16(9):713-22. PubMed ID: 19247396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):240-3. PubMed ID: 15144614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate.
    Mora GR; Olivier KR; Mitchell RF; Jenkins RB; Tindall DJ
    Prostate; 2005 May; 63(2):198-207. PubMed ID: 15486985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis.
    Lowe HC; Fahmy RG; Kavurma MM; Baker A; Chesterman CN; Khachigian LM
    Circ Res; 2001 Oct; 89(8):670-7. PubMed ID: 11597989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
    Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
    Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Skerka C; Decker EL; Zipfel PF
    Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.
    Huang RP; Liu C; Fan Y; Mercola D; Adamson ED
    Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.
    Hao MW; Liang YR; Liu YF; Liu L; Wu MY; Yang HX
    World J Gastroenterol; 2002 Apr; 8(2):203-7. PubMed ID: 11925592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.